Performance of the UCLA Scleroderma Clinical Trials Consortium Gastrointestinal Tract 2.0 instrument as a clinical decision aid in the routine clinical care of patients with systemic sclerosis

go back to reference Meier FMP, Frommer KW, Dinser R, Walker UA, Czirjak L, Denton CP, Allanore Y, Distler O, Riemekasten G, Valentini G, Müller-Ladner U, EUSTAR Co-authors. Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database. Ann Rheum Dis. 2012;71(8):1355–60. https://doi.org/10.1136/annrheumdis-2011-200742.CrossRefPubMed Meier FMP, Frommer KW, Dinser R, Walker UA, Czirjak L, Denton CP, Allanore Y, Distler O, Riemekasten G, Valentini G, Müller-Ladner U, EUSTAR Co-authors. Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database. Ann Rheum Dis. 2012;71(8):1355–60. https://​doi.​org/​10.​1136/​annrheumdis-2011-200742.CrossRefPubMed

go back to reference Elhai M, Meune C, Boubaya M, Avouac J, Hachulla E, Balbir-Gurman A, Riemekasten G, Airò P, Joven B, Vettori S, Cozzi F, Ullman S, Czirják L, Tikly M, Müller-Ladner U, Caramaschi P, Distler O, Iannone F, Ananieva LP, Hesselstrand R, Becvar R, Gabrielli A, Damjanov N, Salvador MJ, Riccieri V, Mihai C, Szücs G, Walker UA, Hunzelmann N, Martinovic D, Smith V, Müller CS, Montecucco CM, Opris D, Ingegnoli F, Vlachoyiannopoulos PG, Stamenkovic B, Rosato E, Heitmann S, Distler JHW, Zenone T, Seidel M, Vacca A, Langhe E, Novak S, Cutolo M, Mouthon L, Henes J, Chizzolini C, Mühlen CAV, Solanki K, Rednic S, Stamp L, Anic B, Santamaria VO, de Santis M, Yavuz S, Sifuentes-Giraldo WA, Chatelus E, Stork J, Laar JV, Loyo E, García de la Peña Lefebvre P, Eyerich K, Cosentino V, Alegre-Sancho JJ, Kowal-Bielecka O, Rey G, Matucci-Cerinic M, Allanore Y, EUSTAR group. Mapping and predicting mortality from systemic sclerosis. Ann Rheum Dis. 2017;76(11):1897–905. https://doi.org/10.1136/annrheumdis-2017-211448.CrossRefPubMed Elhai M, Meune C, Boubaya M, Avouac J, Hachulla E, Balbir-Gurman A, Riemekasten G, Airò P, Joven B, Vettori S, Cozzi F, Ullman S, Czirják L, Tikly M, Müller-Ladner U, Caramaschi P, Distler O, Iannone F, Ananieva LP, Hesselstrand R, Becvar R, Gabrielli A, Damjanov N, Salvador MJ, Riccieri V, Mihai C, Szücs G, Walker UA, Hunzelmann N, Martinovic D, Smith V, Müller CS, Montecucco CM, Opris D, Ingegnoli F, Vlachoyiannopoulos PG, Stamenkovic B, Rosato E, Heitmann S, Distler JHW, Zenone T, Seidel M, Vacca A, Langhe E, Novak S, Cutolo M, Mouthon L, Henes J, Chizzolini C, Mühlen CAV, Solanki K, Rednic S, Stamp L, Anic B, Santamaria VO, de Santis M, Yavuz S, Sifuentes-Giraldo WA, Chatelus E, Stork J, Laar JV, Loyo E, García de la Peña Lefebvre P, Eyerich K, Cosentino V, Alegre-Sancho JJ, Kowal-Bielecka O, Rey G, Matucci-Cerinic M, Allanore Y, EUSTAR group. Mapping and predicting mortality from systemic sclerosis. Ann Rheum Dis. 2017;76(11):1897–905. https://​doi.​org/​10.​1136/​annrheumdis-2017-211448.CrossRefPubMed

go back to reference Yang H, Xu D, Li MT, Yao Y, Jin M, Zeng XF, Qian JM. Gastrointestinal manifestations on impaired quality of life in systemic sclerosis. J Dig Dis. 2019;20(5):256–61. https://doi.org/10.1111/1751-2980.12720.CrossRefPubMed Yang H, Xu D, Li MT, Yao Y, Jin M, Zeng XF, Qian JM. Gastrointestinal manifestations on impaired quality of life in systemic sclerosis. J Dig Dis. 2019;20(5):256–61. https://​doi.​org/​10.​1111/​1751-2980.​12720.CrossRefPubMed

go back to reference Shreiner AB, Murray C, Denton C, Khanna D. Gastrointestinal manifestations of systemic sclerosis. J scleroderma Relat Disord. 2016;1(3):247–56. https://doi.org/10.5301/jsrd.5000214.CrossRefPubMedPubMedCentral Shreiner AB, Murray C, Denton C, Khanna D. Gastrointestinal manifestations of systemic sclerosis. J scleroderma Relat Disord. 2016;1(3):247–56. https://​doi.​org/​10.​5301/​jsrd.​5000214.CrossRefPubMedPubMedCentral

go back to reference Yamamoto M, Takahashi H, Akaike J, Suzuki C, Naishiro Y, Yamamoto H, Imai K, Shinomura Y. Gastric antral vascular ectasia (GAVE) associated with systemic sclerosis. Scand J Rheumatol. 2008;37(4):315–6. https://doi.org/10.1080/03009740801998754.CrossRefPubMed Yamamoto M, Takahashi H, Akaike J, Suzuki C, Naishiro Y, Yamamoto H, Imai K, Shinomura Y. Gastric antral vascular ectasia (GAVE) associated with systemic sclerosis. Scand J Rheumatol. 2008;37(4):315–6. https://​doi.​org/​10.​1080/​0300974080199875​4.CrossRefPubMed

go back to reference Khanna D, Hays RD, Maranian P, Seibold JR, Impens A, Mayes MD, Clements PJ, Getzug T, Fathi N, Bechtel A, Furst DE. Reliability and validity of the University of California, Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument. Arthritis Care Res. 2009;61(9):1257–63. https://doi.org/10.1002/art.24730.CrossRef Khanna D, Hays RD, Maranian P, Seibold JR, Impens A, Mayes MD, Clements PJ, Getzug T, Fathi N, Bechtel A, Furst DE. Reliability and validity of the University of California, Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument. Arthritis Care Res. 2009;61(9):1257–63. https://​doi.​org/​10.​1002/​art.​24730.CrossRef

go back to reference Khanna D, Furst DE, Maranian P, Seibold JR, Impens A, Mayes MD, et al. Minimally important differences of the UCLA scleroderma clinical trial consortium gastrointestinal tract instrument. J Rheumatol. 2011;38(9):1920–4. https://doi.org/10.3899/jrheum.110225.CrossRefPubMedPubMedCentral Khanna D, Furst DE, Maranian P, Seibold JR, Impens A, Mayes MD, et al. Minimally important differences of the UCLA scleroderma clinical trial consortium gastrointestinal tract instrument. J Rheumatol. 2011;38(9):1920–4. https://​doi.​org/​10.​3899/​jrheum.​110225.CrossRefPubMedPubMedCentral

go back to reference Bae S, Allanore Y, Coustet B, Maranian P, Khanna D. Development and validation of French version of the UCLA scleroderma clinical trial consortium gastrointestinal tract instrument. Clin Exp Rheumatol. 2011;29(2 SUPPL. 65):S15-21. Bae S, Allanore Y, Coustet B, Maranian P, Khanna D. Development and validation of French version of the UCLA scleroderma clinical trial consortium gastrointestinal tract instrument. Clin Exp Rheumatol. 2011;29(2 SUPPL. 65):S15-21.

go back to reference Gorga M, Mihai C, Soare AM, Dobrotă R, Gherghe AM, Stoica V. Romanian version of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument. Clin Exp Rheumatol. 2015;33(14):61–7. Gorga M, Mihai C, Soare AM, Dobrotă R, Gherghe AM, Stoica V. Romanian version of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument. Clin Exp Rheumatol. 2015;33(14):61–7.

go back to reference Gualtierotti R, Ingegnoli F, Two R, Meroni PL, Khanna D, Adorni G, et al. Reliability and validity of the Italian version of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument in patients with systemic sclerosis. Clin Exp Rheumatol. 2015;33:55–60. Gualtierotti R, Ingegnoli F, Two R, Meroni PL, Khanna D, Adorni G, et al. Reliability and validity of the Italian version of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument in patients with systemic sclerosis. Clin Exp Rheumatol. 2015;33:55–60.

go back to reference Taş YM, Hakim GD, Keskinoğlu P, Kenar G, Yarkan H, Zengin B, et al. The validity and reliability study of the University of California, Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract (UCLA SCTC GIT) 2.0 questionnaire for the Turkish society. Turkish J Gastroenterol. 2019;30(3):234–41. https://doi.org/10.5152/tjg.2018.17856.CrossRef Taş YM, Hakim GD, Keskinoğlu P, Kenar G, Yarkan H, Zengin B, et al. The validity and reliability study of the University of California, Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract (UCLA SCTC GIT) 2.0 questionnaire for the Turkish society. Turkish J Gastroenterol. 2019;30(3):234–41. https://​doi.​org/​10.​5152/​tjg.​2018.​17856.CrossRef

go back to reference Marighela TF, Arismendi MI, Marvulle V, Brunialti MKC, Salomão R, Kayser C. Effect of probiotics on gastrointestinal symptoms and immune parameters in systemic sclerosis: a randomized placebo-controlled trial. Rheumatol (United Kingdom). 2019;58(11):1985–90. Marighela TF, Arismendi MI, Marvulle V, Brunialti MKC, Salomão R, Kayser C. Effect of probiotics on gastrointestinal symptoms and immune parameters in systemic sclerosis: a randomized placebo-controlled trial. Rheumatol (United Kingdom). 2019;58(11):1985–90.

go back to reference Vigone B, Caronni M, Severino A, Bellocchi C, Baldassarri AR, Fraquelli M, et al. Preliminary safety and efficacy profile of prucalopride in the treatment of systemic sclerosis (SSc)-related intestinal involvement: results from the open label cross-over PROGASS study. Arthritis Res Ther. 2017;19(1):1–8.CrossRef Vigone B, Caronni M, Severino A, Bellocchi C, Baldassarri AR, Fraquelli M, et al. Preliminary safety and efficacy profile of prucalopride in the treatment of systemic sclerosis (SSc)-related intestinal involvement: results from the open label cross-over PROGASS study. Arthritis Res Ther. 2017;19(1):1–8.CrossRef

go back to reference Hsu VM, Denton CP, Domsic RT, Furst DE, Rischmueller M, Stanislav M, Steen VD, Distler JHW, Korish S, Cooper A, Choi S, Schafer PH, Horan G, Hough DR. Pomalidomide in patients with interstitial lung disease due to systemic sclerosis: a phase II, multicenter, randomized, double-blind, placebo-controlled, parallel-group study. J Rheumatol. 2018;45(3):405–10. https://doi.org/10.3899/jrheum.161040.CrossRefPubMed Hsu VM, Denton CP, Domsic RT, Furst DE, Rischmueller M, Stanislav M, Steen VD, Distler JHW, Korish S, Cooper A, Choi S, Schafer PH, Horan G, Hough DR. Pomalidomide in patients with interstitial lung disease due to systemic sclerosis: a phase II, multicenter, randomized, double-blind, placebo-controlled, parallel-group study. J Rheumatol. 2018;45(3):405–10. https://​doi.​org/​10.​3899/​jrheum.​161040.CrossRefPubMed

go back to reference McMahan ZH. Gastrointestinal involvement in systemic sclerosis: an update. Curr Opin Rheumatol. 2019;31(6):561–8. https://doi.org/10.1097/BOR.0000000000000645.CrossRefPubMed McMahan ZH. Gastrointestinal involvement in systemic sclerosis: an update. Curr Opin Rheumatol. 2019;31(6):561–8. https://​doi.​org/​10.​1097/​BOR.​0000000000000645​.CrossRefPubMed

go back to reference Bates D, Mächler M, Bolker BM, Walker SC. Fitting linear mixed-effects models using lme4. J Stat Softw. 2015;67(1):1-48. Bates D, Mächler M, Bolker BM, Walker SC. Fitting linear mixed-effects models using lme4. J Stat Softw. 2015;67(1):1-48.

go back to reference LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TAJ, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol. 1988 Feb;15(2):202–5.PubMed LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TAJ, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol. 1988 Feb;15(2):202–5.PubMed

go back to reference Bae S, Allanore Y, Furst DE, Bodukam V, Coustet B, Morgaceva O, et al. Associations between a scleroderma-specific gastrointestinal instrument and objective tests of upper gastrointestinal involvements in systemic sclerosis. Clin Exp Rheumatol. 2013;31(2 Suppl 76):57-63. Bae S, Allanore Y, Furst DE, Bodukam V, Coustet B, Morgaceva O, et al. Associations between a scleroderma-specific gastrointestinal instrument and objective tests of upper gastrointestinal involvements in systemic sclerosis. Clin Exp Rheumatol. 2013;31(2 Suppl 76):57-63.

go back to reference Abozaid HSM, Imam HMK, Abdelaziz MM, EL-Hammady DH, Fathi NA, Furst DE. High-resolution manometry compared with the University of California, Los Angeles Scleroderma Clinical Trials Consortium GIT 2.0 in Systemic Sclerosis. Semin Arthritis Rheum [Internet]. 2017;47(3):403–8. Abozaid HSM, Imam HMK, Abdelaziz MM, EL-Hammady DH, Fathi NA, Furst DE. High-resolution manometry compared with the University of California, Los Angeles Scleroderma Clinical Trials Consortium GIT 2.0 in Systemic Sclerosis. Semin Arthritis Rheum [Internet]. 2017;47(3):403–8.

go back to reference Abignano G, Mennillo GA, Lettieri G, Temiz Karadag D, Carriero A, Padula AA, et al. UCLA Scleroderma Clinical Trials Consortium Gastrointestinal Tract 2.0 Reflux Scale correlates with impaired Esophageal Scintigraphy findings in Systemic Sclerosis. J Rheumatol. 2021:jrheum.201283. Epub ahead of print. Abignano G, Mennillo GA, Lettieri G, Temiz Karadag D, Carriero A, Padula AA, et al. UCLA Scleroderma Clinical Trials Consortium Gastrointestinal Tract 2.0 Reflux Scale correlates with impaired Esophageal Scintigraphy findings in Systemic Sclerosis. J Rheumatol. 2021:jrheum.201283. Epub ahead of print.

go back to reference Dent J, Vakil N, Jones R, Bytzer P, Schöning U, Halling K, Junghard O, Lind T. Accuracy of the diagnosis of GORD by questionnaire, physicians and a trial of proton pump inhibitor treatment: the Diamond Study. Gut. 2010 Jun;59(6):714–21. https://doi.org/10.1136/gut.2009.200063.CrossRefPubMed Dent J, Vakil N, Jones R, Bytzer P, Schöning U, Halling K, Junghard O, Lind T. Accuracy of the diagnosis of GORD by questionnaire, physicians and a trial of proton pump inhibitor treatment: the Diamond Study. Gut. 2010 Jun;59(6):714–21. https://​doi.​org/​10.​1136/​gut.​2009.​200063.CrossRefPubMed

go back to reference Bolier EA, Kessing BF, Smout AJ, Bredenoord AJ. Systematic review: questionnaires for assessment of gastroesophageal reflux disease. Dis Esophagus. 2015;28(2):105–20. https://doi.org/10.1111/dote.12163.CrossRefPubMed Bolier EA, Kessing BF, Smout AJ, Bredenoord AJ. Systematic review: questionnaires for assessment of gastroesophageal reflux disease. Dis Esophagus. 2015;28(2):105–20. https://​doi.​org/​10.​1111/​dote.​12163.CrossRefPubMed

go back to reference Gyawali CP, Kahrilas PJ. Savarino E, et al. Modern diagnosis of GERD: the Lyon ConsensusGut. 2018;67:1351–62. Gyawali CP, Kahrilas PJ. Savarino E, et al. Modern diagnosis of GERD: the Lyon ConsensusGut. 2018;67:1351–62.

go back to reference Petcu A, Ghib LJ, Grad SM, Popovici C, Rogojan L, Rednic N, Rednic S. Upper gastrointestinal involvement in systemic sclerosis: findings in a real-life setting. Exp Ther Med. 2019;18(6):5095–100. https://doi.org/10.3892/etm.2019.8125.CrossRefPubMedPubMedCentral Petcu A, Ghib LJ, Grad SM, Popovici C, Rogojan L, Rednic N, Rednic S. Upper gastrointestinal involvement in systemic sclerosis: findings in a real-life setting. Exp Ther Med. 2019;18(6):5095–100. https://​doi.​org/​10.​3892/​etm.​2019.​8125.CrossRefPubMedPubMedCentral

go back to reference Thonhofer R, Siegel C, Trummer M, Graninger W. Early endoscopy in systemic sclerosis without gastrointestinal symptoms. Rheumatol Int. 2012;32(1):165–8. https://doi.org/10.1007/s00296-010-1595-y.CrossRefPubMed Thonhofer R, Siegel C, Trummer M, Graninger W. Early endoscopy in systemic sclerosis without gastrointestinal symptoms. Rheumatol Int. 2012;32(1):165–8. https://​doi.​org/​10.​1007/​s00296-010-1595-y.CrossRefPubMed